Page last updated: 2024-12-08

17,20,21-trihydroxy-4-pregnen-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

17,20,21-trihydroxy-4-pregnen-3-one, also known as **17α,20α,21-trihydroxy-4-pregnen-3-one** or **17α,20α,21-trihydroxyprogesterone**, is a steroid hormone with significant research interest.

**Structure and Function:**

* **Structure:** It is a derivative of progesterone, with hydroxyl groups added at positions 17, 20, and 21.
* **Function:** 17α,20α,21-trihydroxyprogesterone is a key intermediate in the biosynthesis of cortisol and corticosterone, two crucial stress hormones produced in the adrenal glands.

**Importance in Research:**

1. **Adrenal Steroidogenesis:** This steroid is crucial for understanding the pathway of cortisol production. Researchers study its synthesis, regulation, and metabolism to understand the mechanisms of adrenal function and dysfunction.

2. **Cortisol Metabolism:** Studying 17α,20α,21-trihydroxyprogesterone helps researchers understand the enzymes involved in cortisol biosynthesis and the potential for enzyme deficiencies that could lead to cortisol deficiency or overproduction.

3. **Drug Development:** 17α,20α,21-trihydroxyprogesterone has shown potential therapeutic effects in various conditions like:
* **Stress Management:** As a precursor to cortisol, it could be explored for its potential in managing stress-related disorders.
* **Inflammation:** Its anti-inflammatory properties have sparked research into its possible use in treating inflammatory conditions.
* **Immune Modulation:** It might play a role in regulating immune responses, making it a potential target for immune disorders.

4. **Analytical Chemistry:** 17α,20α,21-trihydroxyprogesterone is a valuable marker for cortisol production and metabolism. Its presence in various biological fluids (urine, blood) can help researchers assess adrenal function and diagnose conditions like Cushing's syndrome and Addison's disease.

5. **Endocrine Disruptors:** Research explores the potential effects of environmental contaminants on the synthesis and metabolism of 17α,20α,21-trihydroxyprogesterone, investigating the link between endocrine disruption and adrenal function.

**Overall, 17α,20α,21-trihydroxyprogesterone is a crucial molecule in the field of steroid biochemistry and endocrinology. Its research potential extends from understanding fundamental physiological processes to developing novel therapeutic strategies for a wide range of conditions.**

17,20,21-trihydroxy-4-pregnen-3-one: steroid from Micropogonias undulatus during oocyte maturation; RN given for cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID625566
MeSH IDM0147694

Synonyms (5)

Synonym
FT-0665788
17,20,21-trihydroxy-4-pregnen-3-one
17-alpha,20-beta,21-trihydroxypregn-4-en-3-one
17-alpha,20-alpha,21-trihydroxypregn-4-en-3-one
DTXSID60871612

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response experiments with 20 beta-S and 17 alpha,20 beta-dihydroxy-4-pregnen-3-one (17 alpha,20 beta-P) over a range of incubation times yielded similar results for both steroids, suggesting that conversion of 17 alpha,20 beta-P to 20 beta-S is not required for 17 alpha,20 beta-P-induced GVBD."( Induction of maturation of Atlantic croaker oocytes by 17 alpha,20 beta,21-trihydroxy-4-pregnen-3-one in vitro: consideration of some biological and experimental variables.
Patiño, R; Thomas, P, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.81)18.7374
1990's11 (29.73)18.2507
2000's18 (48.65)29.6817
2010's4 (10.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.63%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]